PRIETO VALTUEÑA JESUS MARIA,BUSTOS DE ABAJO MATILDE,MORENO ALIAGA MARIA JESUS
申请号：
IN6089/DELNP/2011
公开号：
IN2011DN06089A
申请日:
2011.08.10
申请国别(地区):
IN
年份:
2012
代理人:
摘要：
The invention is related to the use of cardiotrophin-l (CT-1) for the treatment of obesity and associated disorders: hyperglycaemias, insulin resistance, development of type 2 diabetes and dyslipemias and given its anorexigenic role, fat oxidation stimulant, hypoglycaemic, sensitizing agent of the action of insulin on a skeletal muscle level and inhibitor of the intestinal transport of glucose by enterocytes.
